As seen in Figure 6, PARP9 had a high concordance with prominent immune checkpoint molecules, including PD‐1, PD‐L1, B7‐H3, and TIM‐3, suggesting their synergistic roles in regulating the immune response within the tumor microenvironment. This evidence concerns the gene CD276 and neoplasm.